Mawer Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$141M Sell
267,175
-178,929
-40% -$82.6M 0.96% 27
2026
Q1
$214M Buy
446,104
+38,802
+10% +$19.9M 1.39% 23
2025
Q4
$229M Sell
407,302
-239,472
-37% -$136M 1.28% 23
2025
Q3
$333M Sell
646,774
-170,658
-21% -$74.5M 1.73% 19
2025
Q2
$257M Buy
817,432
+121,213
+17% +$36.4M 1.3% 21
2025
Q1
$212M Buy
+696,219
New +$234M 1.02% 29

Other funds holding MEDP

Mawer Investment Management's MEDP Position: Q2 2026 in Review

Mawer Investment Management reduced its Medpace (MEDP) stake by 40% in Q2 2026, selling an estimated $82.6M and leaving 267,175 shares worth $141M. The position accounts for 0.96% of the portfolio, ranked #27.

Mawer Investment Management first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $333M in Q3 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Mawer Investment Management held 267,175 shares of Medpace worth $141M as of Q2 2026.
  • Mawer Investment Management sold 178,929 Medpace shares in Q2 2026, an estimated $82.6M.
  • Medpace made up 0.96% of Mawer Investment Management's portfolio in Q2 2026, its #27 holding.
  • Mawer Investment Management first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Mawer Investment Management's Medpace position peaked at $333M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Mawer Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.